TY  - JOUR
AU  - Verdugo, Elena
AU  - Puerto, Iker
AU  - Medina, Miguel Ángel
PY  - 2022
DO  - 10.1002/cac2.12361
UR  - http://hdl.handle.net/10668/20952
T2  - Cancer communications (London, England)
AB  - Glioblastoma multiforme (GBM) is the most aggressive and common malignant primary brain tumor. Patients with GBM often have poor prognoses, with a median survival of ∼15 months. Enhanced understanding of the molecular biology of central nervous system...
LA  - en
KW  - cancer molecular biology
KW  - diagnosis
KW  - glioblastoma multiforme
KW  - ongoing clinical trials
KW  - targeted therapy
KW  - tumor heterogeneity
KW  - tumor metabolism
KW  - Humans
KW  - Glioblastoma
KW  - Proto-Oncogene Proteins c-akt
KW  - Phosphatidylinositol 3-Kinases
KW  - TOR Serine-Threonine Kinases
KW  - Molecular Biology
KW  - Tumor Microenvironment
TI  - An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment.
TY  - research article
VL  - 42
ER  -